Journals / Cumhuriyet Science Journal / 2021 / Cilt: 42 - Sayı: 2

Examination of 99mTc-mdp radioactivity after ınjection according to time and distance

Pages
389–396
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results obtained were compared with other studies in the literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In nuclear medicine, the imaging process used to diagnose diseases and to examine the functions of organs is carried out with radiopharmaceuticals containing radioisotope.
📊
Key Findings & Data:In this study, the amount of external radiation emitted from bone scintigraphy patients who were given 99mTc-MDP kit was examined.
💡
Conclusion & Impact:The results obtained were compared with other studies in the literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In nuclear medicine, the imaging process used to diagnose diseases and to examine the functions of organs is carried out with radiopharmaceuticals containing radioisotope. In this study, the amount of external radiation emitted from bone scintigraphy patients who were given 99mTc-MDP kit was examined. The measurements have been performed using FLUKE Victoreen ASM 990 portable detector at Nuclear Medicine Department Medicine Faculty in Tokat Gaziosmanpasa University. The external dose rate values have been measured at 0.50 m, 1.0 m, 2.0 m and 3.0 m away from the patient considered as the source of radiation. All measurements have been taken within approximately one hour and 10 minutes at 10 minutes intervals after injection of the pharmaceutical. In this study, the highest external dose rate value is measured 13.81 μSv h-1 from 0.50 m distance after 30 minutes from the radiopharmaceutical injection and the lowest external dose rate value 1.53 μSv h-1 is obtained from 3.0 m distance after 60 minutes. Then, dose rate values per unit activity were calculated and the highest value was found as 20.57 μSv h-1 GBq-1 30 minutes after injection at 0.50 m. The results obtained were compared with other studies in the literature.

🔖

Cite This Article

COŞKUN, A., GÖKBULUT, M., DEMİR, F., YİĞİTOĞLU, İ., ÇETİN, B. (2022). Examination of 99mTc-mdp radioactivity after ınjection according to time and distance. Cumhuriyet Science Journal, Cilt: 42 - Sayı: 2, 389–396. https://ajindex.com/articles/477581

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Saha G. B., Fundamentals of Nuclear Pharmacy, 6nd ed. London: Springer, (2010) 83-100
  2. Lee Y. S., Radiopharmaceuticals for Molecular Imaging, The Open Nuclear Medicine Journal, 2 (2010) 178-185
  3. Grupen C., Buvat I., Handbook of Particle Detection and Imaging, New York: Springer, (2012) 859-881
  4. Teksöz S., Müftüler F. Z., Nükleer Tıpta Kullanılan Radyoizotoplar ve Biyomedikal Uygulamaları, Nuclear Medicine Seminar, 5 (2019) 10-14
  5. Gündoğdu E. A., Özgenç E., Ekinci M., Özdemir D. İ., Aşıkoglu M., Nükleer Tıpta Görüntüleme ve Tedavide Kullanılan Radyofarmasötikler, Journal of Literature Pharmacy Sciences, 7 (1) (2018) 24-34
  6. Subramanian G., McAfee J. G., Blair R. J., KallfeIz F. A., Thomas, F. D., Technetium-99m- Methylene Diphosphonate a Superior Agent for Skeletal İmaging: Comparison with other Technetium Complexes, Journal of Nuclear Medicine, 16 (1975) 744-755
  7. Önsel Ç., Kantarcı F., Görüntüleme Yöntemleri Sempozyumu, İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi Sürekli Tıp Eğitimi Etkinlikleri. Birinci Basım, İstanbul, 2010
  8. Salmanoğlu E., Peksoy İ., Tc-99m MDP’nin intraarteryal enjeksiyonu, Cukurova Medical Journal, 41(1) (2016) 75-78
  9. IAEA., International basic safety standards for protection against ionizing radiation and for the safety of radiation sources, International Atomic Energy Agency. Safety Series No
  10. Vienna, (1996) 20-30
  11. Valantin J., Radiological Protection in Medicine. ICRP Publication 105. Ann. ICRP 3 (2008) 17-22
  12. Eckerman K., Harrison J., Menzel H. G., Clement C. H., Compendium of Dose Coefficients based on ICRP Publication 60. ICRP Publication 119, Ann. ICRP, 41(1) (2011) 13-22
  13. IAEA., Release of Patients After Radionuclide Therapy, International Atomic Energy Agency. Safety Report Series No
  14. Vienna, (2009) 3-15
  15. TAEK., Radyonüklit Tedavisi Gören Hastaların Taburcu Edilmesine İlişkin Kılavuz. Ankara: RSGD-KLV-009 (Rev.2), Türkiye Atom Enerji Kurumu, (2016) 7-22
  16. ASM 990 Series, Advanced Survey Meter, Available at: https://www.flukebiomedical.com/products/radia tion-measurement. Retrieved March 25, 2020
  17. Chabot G., Instrumentation and Measurements Surveys and Measurements (SM), Health Physics Society, Available at: http://hps.org/publicinformation/ate/q4148.html. Retrieved May 25, 2020
  18. Vennart J., Radiation Dose to Patients from Radiopharmaceutcals, ICRP Publication 53. Ann. ICRP, 18 (1-4) (1998) 213-217
  19. Bartlett M. L., Estimated Dose From Diagnos